AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 100 filers reported holding AKCEA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,172,000 | -69.2% | 340,264 | -76.7% | 0.08% | -70.1% |
| Q2 2020 | $20,033,000 | -56.3% | 1,462,296 | -54.4% | 0.28% | -68.1% |
| Q1 2020 | $45,821,000 | -14.5% | 3,204,244 | +1.3% | 0.89% | +4.7% |
| Q4 2019 | $53,575,000 | +11.9% | 3,162,643 | +1.7% | 0.85% | -4.6% |
| Q3 2019 | $47,861,000 | -34.2% | 3,109,911 | +0.3% | 0.89% | -28.3% |
| Q2 2019 | $72,713,000 | +408.8% | 3,100,768 | +514.7% | 1.24% | +58.0% |
| Q1 2019 | $14,290,000 | +3.5% | 504,411 | +10.1% | 0.79% | -13.4% |
| Q4 2018 | $13,813,000 | -5.8% | 458,296 | +9.5% | 0.91% | -2.4% |
| Q3 2018 | $14,656,000 | +63.0% | 418,496 | +10.3% | 0.93% | +21.3% |
| Q2 2018 | $8,993,000 | +619.4% | 379,301 | +677.3% | 0.77% | +518.5% |
| Q1 2018 | $1,250,000 | – | 48,799 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |